(Q38248546)

1 September 2017

1 reference

title

MMPs: a novel drug target for schizophrenia (English)

1 reference

1 September 2017

0 references

Kanwaljit Chopra

1

1 reference

1 September 2017

Ankita Baveja

series ordinal

2

1 reference

1 September 2017

Anurag Kuhad

series ordinal

3

1 reference

1 September 2017

language of work or name

English

0 references

publication date

12 September 2014

1 reference

Expert Opinion on Therapeutic Targets

1 September 2017

1 reference

1 September 2017

19

1 reference

1 September 2017

1

1 reference

1 September 2017

77-85

1 reference

Schizophrenia, "just the facts" 4. Clinical features and conceptualization

1 September 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Animal models of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Schizophrenia: from phenomenology to neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Adolescent onset of cortical disinhibition in schizophrenia: insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Drug discovery in the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Extracellular matrix abnormalities in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix regulators in neural stem cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Contributions of astrocytes to synapse formation and maturation - Potential functions of the perisynaptic extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Reelin, very-low-density lipoprotein receptor, and apolipoprotein E receptor 2 control somatic NMDA receptor composition during hippocampal maturation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix metalloproteinases: useful and deleterious

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix metalloproteinases in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Progress in matrix metalloproteinase research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Do schizophrenia and bipolar disorders share a common disease susceptibility variant at the MMP3 gene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Autoantibodies from schizophrenia patients induce cerebral cox-1/iNOS mRNA expression with NO/PGE2/MMP-3 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix metalloproteinases: they're not just for matrix anymore!

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Chondroitin sulphate proteoglycans: extracellular matrix proteins that regulate immunity of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Albumin induces upregulation of matrix metalloproteinase-9 in astrocytes via MAPK and reactive oxygen species-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

The matrix metalloproteinases and CNS plasticity: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Regulated proteolytic processing of Reelin through interplay of tissue plasminogen activator (tPA), ADAMTS-4, ADAMTS-5, and their modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Structure and function of matrix metalloproteinases and TIMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Tetracyclines: nonantibiotic properties and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

Estrogen augmentation in schizophrenia: a quantitative review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.957672

10.1517/14728222.2014.957672

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference